These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 22480390)
1. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma. Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390 [TBL] [Abstract][Full Text] [Related]
2. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma. Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674 [TBL] [Abstract][Full Text] [Related]
3. High expression of p300 has an unfavorable impact on survival in resectable esophageal squamous cell carcinoma. Li Y; Yang HX; Luo RZ; Zhang Y; Li M; Wang X; Jia WH Ann Thorac Surg; 2011 May; 91(5):1531-8. PubMed ID: 21524463 [TBL] [Abstract][Full Text] [Related]
4. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma. Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008 [TBL] [Abstract][Full Text] [Related]
5. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma. Li Y; Yu H; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH J Surg Oncol; 2011 Nov; 104(6):617-22. PubMed ID: 21744352 [TBL] [Abstract][Full Text] [Related]
6. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196 [TBL] [Abstract][Full Text] [Related]
7. High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinoma. Li Y; Wen ZS; Yang HX; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH Ann Surg Oncol; 2011 Nov; 18(12):3370-6. PubMed ID: 21630125 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases. J Am Coll Surg; 2001 Jun; 192(6):708-18. PubMed ID: 11400964 [TBL] [Abstract][Full Text] [Related]
9. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206 [TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma]. Zhang Y; Liu YP; Du K; Wang H; Wang XL Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219 [TBL] [Abstract][Full Text] [Related]
12. Positive transforming growth factor-β activated kinase-1 expression has an unfavorable impact on survival in T3N1-3M0 esophageal squamous cell carcinomas. Wen J; Hu Y; Luo KJ; Yang H; Zhang SS; Fu JH Ann Thorac Surg; 2013 Jan; 95(1):285-90. PubMed ID: 23272845 [TBL] [Abstract][Full Text] [Related]
13. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases. Lee PC; Port JL; Paul S; Stiles BM; Altorki NK Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222 [TBL] [Abstract][Full Text] [Related]
14. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas. Brücher BL; Becker K; Lordick F; Fink U; Sarbia M; Stein H; Busch R; Zimmermann F; Molls M; Höfler H; Siewert JR Cancer; 2006 May; 106(10):2119-27. PubMed ID: 16607651 [TBL] [Abstract][Full Text] [Related]
15. Total number of resected lymph nodes predicts survival in esophageal cancer. Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631 [TBL] [Abstract][Full Text] [Related]
16. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers. Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742 [TBL] [Abstract][Full Text] [Related]
17. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865 [TBL] [Abstract][Full Text] [Related]
18. [Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy]. Zhang DK; Su XD; Lin P Ai Zheng; 2008 Feb; 27(2):113-8. PubMed ID: 18279605 [TBL] [Abstract][Full Text] [Related]
19. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma. Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Kidogami S; Miyata H; Takiguchi S; Fujiwara Y; Yasuda T; Yano M; Nakamori S; Sakon M; Monden M; Aozasa K Clin Cancer Res; 2004 Aug; 10(16):5558-65. PubMed ID: 15328197 [TBL] [Abstract][Full Text] [Related]
20. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy? Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]